Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Watch this 2012 Mini-Psych school class "Preventing Alzheimer's Disease: an impossible dream?" by John Breitner

Interview with Naguib Mechawar, PhD, director of the Mood, Anxiety and Impulsity-related diseases research theme.

Why is an early diagnosis of Alzheimer's Disease useful?